Table 2.
Results of Spearman correlation analysis among pain-related variables
| Pain (+) | Pain as primary symptom | Time onset of pain | Ongoing pain | Widespread pain | VAS | ||
|---|---|---|---|---|---|---|---|
| Pain (+) | rho | 1 | .460** | .801** | .110 | .587** | .816** |
| P | .000 | .000 | .131 | .000 | .000 | ||
| Pain as primary symptom | rho | .460** | 1 | .528** | .166* | .356** | .556** |
| P | .000 | .000 | .021 | .000 | .000 | ||
| Time onset of pain | rho | .801** | .528** | 1 | .163* | .488** | .741* |
| P | .000 | .000 | .029 | .000 | .000 | ||
| Ongoing pain | rho | .110 | .166* | .163* | 1 | .055 | .190** |
| P | .131 | .021 | .029 | .452 | .009 | ||
| Widespread pain | rho | .587** | .356** | .488** | .055 | 1 | .531** |
| P | .000 | .000 | .000 | .452 | .000 | ||
| VAS | rho | .816** | .556** | .741* | .190** | .531** | 1 |
| P | .000 | .000 | .000 | .009 | .000 | ||
*Significant at the 0.05 level. **Significant at the 0.01 level